Fedha

Hisa unazofuatilia
NONOF:OTCMKTS
Novo Nordisk A/S
US$ 38.03
-0.31%
(-0.12) Siku 1
1 Okt, 15:23:49 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya NONOF...
Fungua
US$ 35.86
Juu
US$ 38.36
Chini
US$ 35.86
Mtaji wa soko
129.02B
Wastani wa kiasi cha mauzo
elfu 134.15
Kiasi cha mauzo ya hisa
elfu 11.05
Juu kwa wiki 52
US$ 64.75
Chini kwa wiki 52
US$ 34.00
Beta
0.63
Hisa za wawekezaji
3.39B
Idadi ya wafanyakazi
elfu 67
Fungua
US$ 35.86
Juu
US$ 38.36
Chini
US$ 35.86
Mtaji wa soko
129.02B
Wastani wa kiasi cha mauzo
elfu 134.15
Kiasi cha mauzo ya hisa
elfu 11.05
Juu kwa wiki 52
US$ 64.75
Chini kwa wiki 52
US$ 34.00
Beta
0.63
Hisa za wawekezaji
3.39B
Idadi ya wafanyakazi
elfu 67
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Novo is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s. Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds approximately 28.1% of its shares and a majority of its voting shares. Novo is a full member of the European Federation of Pharmaceutical Industries and Associations. The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten. Novo is the largest pharmaceutical company in Denmark. Wikipedia
Kuhusu Novo Nordisk A/S
Afisa Mkuu Mtendaji (CEO)Maziar Mike Doustdar
Wafanyakazielfu 66.7
Lilianzishwa21 Des 1923
Makao makuuBagsværd, Capital Region of Denmark, Denmaki
Sekta-
Ripoti za awaliThamani zote katika DKK
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika DKK
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
74.98B
79.14B
96.82B
78.49B
Gharama ya bidhaa zilizouzwa
14.47B
14.17B
13.60B
17.10B
Gharama ya mapato
14.47B
14.17B
13.60B
17.10B
Gharama za utafiti na maendeleo
11.49B
12.67B
10.28B
11.46B
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
15.76B
17.14B
13.22B
16.31B
Gharama ya uendeshaji
27.25B
29.73B
23.61B
28.00B
Jumla ya gharama za uendeshaji
41.72B
43.90B
37.20B
45.10B
Mapato ya uendeshaji
33.25B
35.24B
59.62B
33.39B
Mapato mengine yasiyo ya uendeshaji
1.53B
-241.00M
-
-
EBT ikijumuisha vipengee visivyo vya kawaida
25.52B
34.18B
62.17B
26.88B
EBT bila kujumuisha vipengee visivyo vya kawaida
35.09B
37.62B
62.17B
33.20B
Gharama ya kodi ya mapato
5.51B
7.29B
13.62B
5.89B
Kiwango cha kodi kinachotumika
21.60%
21.34%
21.90%
21.90%
Gharama nyingine za uendeshaji
-
-81.00M
106.00M
234.00M
Mapato halisi
20.01B
26.89B
48.56B
20.99B
Kiwango cha faida halisi
26.68%
33.98%
50.15%
26.74%
Mapato kwa kila hisa
4.50
6.04
6.63
6.18
Mapato ya riba na uwekezaji
307.00M
4.41B
-
1.31B
Gharama ya riba
-
-4.97B
-
-1.50B
Jumla ya gharama halisi za riba
307.00M
-560.00M
-
-186.00M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
36.49B
36.66B
63.13B
36.99B
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google